The DOI matches its Crossref record, with a small difference in title or year; 36 of the 36 references it cites were found in a registry or an index.
AHA/ACC Guidelines for Preventing Heart Attack and Death in Patients With Atherosclerotic Cardiovascular Disease: 2001 Update: A Statement for Healthcare Professionals From the American Heart Association and the American College of Cardiology
Open accessAbstract
Since the original publication (in 1995) of the American Heart Association (AHA) consensus statement on secondary prevention, which was endorsed by the American College of Cardiology (ACC), important evidence from clinical trials has emerged that further supports the merits of aggressive risk reduction therapies for patients with atherosclerotic cardiovascular disease. As noted in that statement, aggressive risk factor management clearly improves patient survival, reduces recurrent events and the need for interventional procedures, and improves the quality of life for these patients. The compelling evidence from some recent clinical trials was the impetus to revise the 1995 guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The introduction of an intensive, educational, and process-orientated quality-improvement initiative, based on the 2001 American College of Cardiology/AHA secondary prevention guidelines, 558 resulted in significantly improved compliance rates at discharge for aspirin, ACE inhibitors, lipid-lowering drugs, smoking cessation counselling, and dietary counselling.559”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [558]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Self-citationExpert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
(1996) · The Lancet · doi:10.1016/s0140-6736(96)09457-3 · Cited by 6,503
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
Self-citationBraunwald, E., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,475
Self-citationAltman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · BMJ · doi:10.1136/bmj.308.6921.81 · Cited by 4,204
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
SCANDINAVIANSIMVASTATINSURVIVAL (1994) · The Lancet · doi:10.1016/s0140-6736(94)90566-5 · Cited by 3,638
Altman, R., Carreras, L., Díaz, R. S., Figueroa, E. B., Paolasso, E., Parodi, J. C., Cade, J. F., Donnan, G. A., Eadie, M. J., Gavaghan, T. P., et al. (1994) · Cited by 3,322
Grundy, S. M., Benjamin, I. J., Burke, G. L., Chait, A., Eckel, R. H., Howard, B. V., Mitch, W., Smith, S. C., & Sowers, J. R. (1999) · Circulation · doi:10.1161/01.cir.100.10.1134 · Cited by 2,698
Self-citationACC/AHA guidelines for the management of patients with acute myocardial infarction
Ryan, T. J., Anderson, J. L., Antman, E. M., Braniff, B. A., Brooks, N. H., Califf, R. M., Hillis, L. D., Hiratzka, L. F., Rapaport, E., Riegel, B. J., et al. (1996) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(96)00392-0 · Cited by 1,962
Fletcher, G. F., Balady, G. J., Amsterdam, E. A., Chaitman, B., Eckel, R., Fleg, J., Froelicher, V. F., Leon, A. S., Piña, I. L., Rodney, R., et al. (2001) · Circulation · doi:10.1161/hc3901.095960 · Cited by 1,923
The Norwegian Multicenter Study Group (1981) · New England Journal of Medicine · doi:10.1056/nejm198104023041401 · Cited by 1,674
Secondary prevention of vascular disease by prolonged antiplatelet treatment
Antiplatelet Trialists' Collaboration (1988) · BMJ · doi:10.1136/bmj.296.6618.320 · Cited by 1,048
A Case-Management System for Coronary Risk Factor Modification after Acute Myocardial Infarction
DeBusk, R. F., Miller, N. H., Superko, H. R., Dennis, C. A., Thomas, R. J., Lew, H. T., Berger, W. E., Heller, R. S., Rompf, J., Gee, D., et al. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-9-199405010-00001 · Cited by 745
Self-citationThe Effect of Warfarin on Mortality and Reinfarction after Myocardial Infarction
Smith, P., Arnesen, H., & Holme, I. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007193230302 · Cited by 637
Fonarow, G. C., Gawlinski, A., Moughrabi, S. M., & Tillisch, J. H. (2001) · The American Journal of Cardiology · doi:10.1016/s0002-9149(00)01519-8 · Cited by 511
Hormone Replacement Therapy and Cardiovascular Disease
Mosca, L. J., Collins, P. D., Herrington, D. M., Mendelsohn, M. E., Pasternak, R. C., Robertson, R. M., Schenck-Gustafsson, K. G., Smith, S. C., Taubert, K. A., & WENGER, N. K. (2001) · Circulation · doi:10.1161/hc2901.092200 · Cited by 437
Self-citationHambrecht, R., Niebauer, J., Marburger, C., Grunze, M. F., Kälberer, B., Hauer, K. A., Schlierf, G., Kübler, W., & Schuler, G. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90051-2 · Cited by 430
American Diabetes Association: clinical practice recommendations 1996.
(1996) · PubMed · Cited by 428
The Antiplatelet Effects of Ticlopidine and Clopidogrel
Sharis, P. J., Cannon, C. P., & Loscalzo, J. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-5-199809010-00009 · Cited by 328
Preventing heart attack and death in patients with coronary disease
Smith, S. C., Blair, S. N., Criqui, M. H., Fletcher, G. F., Fuster, V., Gersh, B. J., Gotto, A. M., Gould, K. L., Greenland, P., Grundy, S. M., et al. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)90846-g · Cited by 325
Self-citationCost-effectiveness of a smoking cessation program after myocardial infarction
Krumholz, H. M., Cohen, B. J., Tsevat, J., Pasternak, R. C., & Weinstein, M. C. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90598-u · Cited by 137
Self-citationO’Keefe, J. H., Wetzel, M., Moe, R. M., Brosnahan, K., & Lavie, C. J. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01044-5 · Cited by 118
Viscoli, C. M., Horwitz, R. I., & Singer, B. H. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-2-199301150-00004 · Cited by 85
ACE Inhibition in Acute Myocardial Infarction
Pfeffer, M. A. (1995) · New England Journal of Medicine · doi:10.1056/nejm199501123320210 · Cited by 76
Self-citationPearson, T. A., Rapaport, E., Criqui, M. H., Furberg, C. D., Fuster, V., Hiratzka, L., Little, W., Ockene, I. S., & Williams, G. H. (1994) · Circulation · doi:10.1161/01.cir.90.6.3125 · Cited by 66
Self-citationQuinn, T. G., Alderman, E. L., McMillan, A., & Haskell, W. L. (1994) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)90848-6 · Cited by 43
Economics and Efficacy in Choosing Oral Anticoagulants or Aspirin After Myocardial Infarction
Cairns, J. A. (1995) · JAMA · doi:10.1001/jama.1995.03520360079044 · Cited by 28
Guidelines for the Management of Patients with Chronic Stable Angina
Modest, G. A. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00028 · Cited by 26
Effects of long-term anticoagulant therapy in subgroups after acute myocardial infarction.
Smith, P., Arnesen, H., & Abdelnoor, M. (1992) · PubMed · Cited by 18
Pfeffer, M. A., DOMANSKI, M. J., Verter, J. I., Dunlap, M. E., Flaker, G. C., Gersh, B. J., Hsia, J. A., Goldberg, A. D., Limacher, M. C., Maggioni, A. P., et al. (2001) · American Heart Journal · doi:10.1067/mhj.2001.117603 · Cited by 18
Self-citationPepine, C. J. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00346-5 · Cited by 12
Effects of Long-term Anticoagulant Therapy in Subgroups After Acute Myocardial Infarction
Smith, P. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400170079015 · Cited by 10
Flagged first, then by citations
Cited by
Sorted by citations
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Antman, E. M., Anbe, D. T., Armstrong, P. W., Bates, E., Green, L. A., Hand, M. M., Hochman, J. S., Krumholz, H. M., Kushner, F. G., Lamas, G. A., et al. (2004) · Circulation · doi:10.1161/01.cir.0000134791.68010.fa · Cited by 8,348
Self-citationInter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,137
European guidelines on cardiovascular disease prevention in clinical practice: executive summary
Graham, I., Atar, D., Borch‐Johnsen, K., Boysen, G., Burell, G. K., Cífková, R., Dallongeville, J., Backer, G. D., Ebrahim, S. B. J., Gjelsvik, B., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm316 · Cited by 3,865
Metadata
- Authors
- Smith, S. C., Blair, S. N., Bonow, R. O., Brass, L. M., Cerqueira, M. D., Dracup, K., Fuster, V., Gotto, A., Grundy, S. M., Miller, N. H., Jacobs, A., Jones, D., Krauss, R. M., Mosca, L., Ockene, I., Pasternak, R. C., Pearson, T., Pfeffer, M. A., Starke, R. D., & Taubert, K. A.
- Affiliations
- American Heart Association (US)
- The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest., This statement was approved by the American Heart...
- ORCID
- Venue
- Circulation
- Published
- 2001-09-25
- Volume
- 104
- Issue
- 13
- Pages
- 1577-1579
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2913860186
- Cited by
- 661
- References
- 36
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 6 · 2022: 8 · 2021: 2 · 2020: 2 · 2019: 8 · 2018: 6 · 2017: 5 · 2016: 14 · 2015: 16 · 2014: 18 · 2013: 22 · 2012: 20
- FWCI
- 60.69
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- eScholarship@UMassChan (submittedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- secondary prevention, atherosclerotic cardiovascular disease, cardiovascular risk management, myocardial infarction prevention, cardiovascular mortality, recurrent cardiovascular events, clinical trial evidence
- MeSH terms
- American Heart Association, Arteriosclerosis, Cardiovascular Diseases, Heart Arrest, Humans, Preventive Medicine, Rehabilitation, United States, Death, Sudden, Cardiac, Practice Guidelines as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review